English

BioStock: Evaxion to sharpen focus and launch new platform

Report this content

Danish Evaxion Biotech continues to leverage its core AI capabilities. The company has launched the new ObsERV platform and increased focus on target discovery and early out-licensing opportunities. BioStock contacted CEO Per Norlén to find out more about what this means for the company.

Read the interview with Per Norlén at biostock.se:

Evaxion to sharpen focus and launch new platform - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Subscribe

Documents & Links

Quick facts

BioStock: Evaxion to sharpen focus and launch new platform
Tweet this